Benzinga | Oct 6, 2021 06:49AM EDT

Barclays Upgrades Ambev to Overweight, Lowers Price Target to $3.5

Barclays analyst Benjamin Theurer upgrades Ambev (NYSE:ABEV) from Equal-Weight to Overweight and lowers the price target from $4 to $3.5.